These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 30452418)

  • 21. Streptozotocin Intracerebroventricular-Induced Neurotoxicity and Brain Insulin Resistance: a Therapeutic Intervention for Treatment of Sporadic Alzheimer's Disease (sAD)-Like Pathology.
    Kamat PK; Kalani A; Rai S; Tota SK; Kumar A; Ahmad AS
    Mol Neurobiol; 2016 Sep; 53(7):4548-62. PubMed ID: 26298663
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MiR-26b, upregulated in Alzheimer's disease, activates cell cycle entry, tau-phosphorylation, and apoptosis in postmitotic neurons.
    Absalon S; Kochanek DM; Raghavan V; Krichevsky AM
    J Neurosci; 2013 Sep; 33(37):14645-59. PubMed ID: 24027266
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Altered calcium signaling and neuronal injury: stroke and Alzheimer's disease as examples.
    Mattson MP; Rydel RE; Lieberburg I; Smith-Swintosky VL
    Ann N Y Acad Sci; 1993 May; 679():1-21. PubMed ID: 8512177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The cell cycle as a therapeutic target for Alzheimer's disease.
    Neve RL; McPhie DL
    Pharmacol Ther; 2006 Jul; 111(1):99-113. PubMed ID: 16274748
    [TBL] [Abstract][Full Text] [Related]  

  • 25. mTORC2 (Rictor) in Alzheimer's Disease and Reversal of Amyloid-β Expression-Induced Insulin Resistance and Toxicity in Rat Primary Cortical Neurons.
    Lee HK; Kwon B; Lemere CA; de la Monte S; Itamura K; Ha AY; Querfurth HW
    J Alzheimers Dis; 2017; 56(3):1015-1036. PubMed ID: 28035937
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Abeta oligomers induce neuronal cell cycle events in Alzheimer's disease.
    Varvel NH; Bhaskar K; Patil AR; Pimplikar SW; Herrup K; Lamb BT
    J Neurosci; 2008 Oct; 28(43):10786-93. PubMed ID: 18945886
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Brain insulin resistance and deficiency as therapeutic targets in Alzheimer's disease.
    de la Monte SM
    Curr Alzheimer Res; 2012 Jan; 9(1):35-66. PubMed ID: 22329651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
    Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
    Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Abeta treatment and P301L tau expression in an Alzheimer's disease tissue culture model act synergistically to promote aberrant cell cycle re-entry.
    Hoerndli FJ; Pelech S; Papassotiropoulos A; Götz J
    Eur J Neurosci; 2007 Jul; 26(1):60-72. PubMed ID: 17587323
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cell cycle activation and aneuploid neurons in Alzheimer's disease.
    Arendt T
    Mol Neurobiol; 2012 Aug; 46(1):125-35. PubMed ID: 22528601
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Perinuclear Lamin A and Nucleoplasmic Lamin B2 Characterize Two Types of Hippocampal Neurons through Alzheimer's Disease Progression.
    Gil L; Niño SA; Chi-Ahumada E; Rodríguez-Leyva I; Guerrero C; Rebolledo AB; Arias JA; Jiménez-Capdeville ME
    Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32155994
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of neuronal insulin/insulin-like growth factor-1 signaling for the pathogenesis of Alzheimer's disease: possible therapeutic implications.
    Zemva J; Schubert M
    CNS Neurol Disord Drug Targets; 2014 Mar; 13(2):322-37. PubMed ID: 24059318
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer's disease.
    Pulliam L; Sun B; Mustapic M; Chawla S; Kapogiannis D
    J Neurovirol; 2019 Oct; 25(5):702-709. PubMed ID: 30610738
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gliosis Precedes Amyloid-β Deposition and Pathological Tau Accumulation in the Neuronal Cell Cycle Re-Entry Mouse Model of Alzheimer's Disease.
    Park KHJ; Barrett T
    J Alzheimers Dis Rep; 2020 Jul; 4(1):243-253. PubMed ID: 32904753
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Model scenarios for cell cycle re-entry in Alzheimer's disease.
    Pandey N; Vinod PK
    iScience; 2022 Jul; 25(7):104543. PubMed ID: 35747391
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aberrant insulin signaling in Alzheimer's disease: current knowledge.
    Bedse G; Di Domenico F; Serviddio G; Cassano T
    Front Neurosci; 2015; 9():204. PubMed ID: 26136647
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The endocrine dyscrasia that accompanies menopause and andropause induces aberrant cell cycle signaling that triggers re-entry of post-mitotic neurons into the cell cycle, neurodysfunction, neurodegeneration and cognitive disease.
    Atwood CS; Bowen RL
    Horm Behav; 2015 Nov; 76():63-80. PubMed ID: 26188949
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bidirectional modulation of Alzheimer phenotype by alpha-synuclein in mice and primary neurons.
    Khan SS; LaCroix M; Boyle G; Sherman MA; Brown JL; Amar F; Aldaco J; Lee MK; Bloom GS; Lesné SE
    Acta Neuropathol; 2018 Oct; 136(4):589-605. PubMed ID: 29995210
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of cell cycle-mediated events in Alzheimer's disease.
    Raina AK; Monteiro MJ; McShea A; Smith MA
    Int J Exp Pathol; 1999 Apr; 80(2):71-6. PubMed ID: 10469261
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Loss of neuronal cell cycle control as a mechanism of neurodegeneration in the presenilin-1 Alzheimer's disease brain.
    Malik B; Currais A; Andres A; Towlson C; Pitsi D; Nunes A; Niblock M; Cooper J; Hortobágyi T; Soriano S
    Cell Cycle; 2008 Mar; 7(5):637-46. PubMed ID: 18239458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.